Prevalence of Hepatitis C Virus Seropositivity and Its Impact on Coronary Artery Disease among Egyptian Patients Referred for Coronary Angiography

Table 1

Demographic and clinical characteristics of the CAD positive and CAD negative groups.

Variable	Group 1 CAD positive ()	Group 2 CAD negative ()	value	OR (95% CI)
Age (years)	53.37 ± 8.36	54.49 ± 9.93	0.38
Gender
(i) Male (%)	195 (56.7%)	108 (65.5%)	0.059
(ii) Female (%)	149 (43.3%)	57 (34.5%)
Risk factors
(i) DM	175 (50.9%)	51 (30.9%)	<0.0001	2.32
(ii) HTN	230 (66.9%)	72 (43.6%)	<0.0001	2.6
(iii) Dyslipidemia	229 (66.6%)	84 (50.9%)	0.001	1.92
(iv) Smokers	153 (44.5%)	51 (30.9%)	0.003	1.79
(v) Positive family history	81 (23.5%)	27 (16.4%)	0.06
Clinical presentation
(i) Stress positive test (%)	15 (4.4%)	33 (20%)	<0.0001
(ii) Unstable angina (%)	129 (37.5%)	126 (76.4%)
(iii) NSTEMI (%)	76 (22.1%)	0 (0%)
(iv) STEMI (%)	124 (36%)	6 (3.6%)
Prevalence of HCV	118 (34.3%)	36 (21.8%)	0.004	1.87

CAD = coronary artery disease, NSTEMI = non-ST segment elevation myocardial infarction, STEMI = ST segment elevation myocardial infarction, = number, = mean, SD = standard deviation, OR = odds ratio, and CI = confidence interval.